- Home
- MNYWW vs IMNM Comparison
MNYWW vs IMNM Comparison
Compare MNYWW & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNYWW
- IMNM
- Stock Information
- Founded
- MNYWW N/A
- IMNM 2006
- Country
- MNYWW Singapore
- IMNM United States
- Employees
- MNYWW 366
- IMNM N/A
- Industry
- MNYWW
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- MNYWW
- IMNM Health Care
- Exchange
- MNYWW Nasdaq
- IMNM Nasdaq
- Market Cap
- MNYWW N/A
- IMNM 747.7M
- IPO Year
- MNYWW N/A
- IMNM 2020
- Fundamental
- Price
- MNYWW $0.04
- IMNM $12.45
- Analyst Decision
- MNYWW
- IMNM Strong Buy
- Analyst Count
- MNYWW 0
- IMNM 4
- Target Price
- MNYWW N/A
- IMNM $28.75
- AVG Volume (30 Days)
- MNYWW N/A
- IMNM 801.6K
- Earning Date
- MNYWW N/A
- IMNM 11-07-2024
- Dividend Yield
- MNYWW N/A
- IMNM N/A
- EPS Growth
- MNYWW N/A
- IMNM N/A
- EPS
- MNYWW N/A
- IMNM N/A
- Revenue
- MNYWW N/A
- IMNM $10,784,000.00
- Revenue This Year
- MNYWW N/A
- IMNM N/A
- Revenue Next Year
- MNYWW N/A
- IMNM N/A
- P/E Ratio
- MNYWW N/A
- IMNM N/A
- Revenue Growth
- MNYWW N/A
- IMNM 62.73
- 52 Week Low
- MNYWW N/A
- IMNM $6.93
- 52 Week High
- MNYWW N/A
- IMNM $30.96
- Technical
- Relative Strength Index (RSI)
- MNYWW 47.73
- IMNM 34.11
- Support Level
- MNYWW $0.03
- IMNM $12.90
- Resistance Level
- MNYWW $0.05
- IMNM $13.91
- Average True Range (ATR)
- MNYWW 0.01
- IMNM 0.86
- MACD
- MNYWW 0.00
- IMNM -0.25
- Stochastic Oscillator
- MNYWW 47.62
- IMNM 4.87
About MNYWW MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.